Check Cap Ltd (NASDAQ:CHEK) is set to post its quarterly earnings results on Thursday, October 20th. Analysts expect Check Cap to post earnings of ($0.19) per share for the quarter.

Check Cap Ltd (NASDAQ:CHEK) opened at 1.82 on Wednesday. The firm’s market capitalization is $22.30 million. Check Cap Ltd has a one year low of $0.97 and a one year high of $3.72. The firm has a 50-day moving average price of $1.99 and a 200 day moving average price of $1.98.

Several brokerages have weighed in on CHEK. Zacks Investment Research lowered Check Cap from a “buy” rating to a “hold” rating in a report on Wednesday, July 20th. Maxim Group increased their price objective on Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a report on Monday, August 1st.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Check Cap Company Profile

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.

5 Day Chart for NASDAQ:CHEK

Receive News & Ratings for Check Cap Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap Ltd and related companies with's FREE daily email newsletter.